As Pandemic Persists, TAU Forges Ahead with COVID-19 Research on All Fronts

Written on |

The University’s Center for Combating Pandemics leads research efforts in a range of fields.

As the COVID-19 pandemic nears the end of a second year, Tel Aviv University is maintaining its fast pace of scientific discovery in the global battle against coronavirus.  

Building on the University’s innovation record, TAU in 2020 launched the Center for Combating Pandemics. The Center harnesses the collective power of academia, hospitals, government and industry to promote research and guide government policy. It is the first entity of its kind in Israel, and potentially the world.  

Members of the Center include more than 100 research groups comprised of top TAU experts from all scientific disciplines across campus. Among them, over 60 researchers have, until now, conducted projects related to COVID-19. 

Academic Powerhouse

To date, the Center’s members have published findings from dozens of COVID-19 studies. Select examples include: 

Prof. Noam Shomron (Medicine) spearheaded a novel approach to remote monitoring of COVID-19 patients that flags early cardiovascular warnings of worsening health. More here.  

Prof. Shoshana Shiloh (Social Sciences) and team devised a model to determine the psychological and social factors that predict who will voluntarily take the COVID-19 vaccine.  

Prof. Dan Yamin’s (Engineering) lab developed a “big data” COVID-19 detection technology that could be used to reduce viral spread and help shape more efficient testing policy. More here.  

Prof. Isaac Sasson (Engineering) led a study to help improve understanding of COVID-19 mortality and age in countries with limited data. More here.  

A team led by Prof. Saharon Rosset (Exact Sciences) built a statistical model to better understand SARS-CoV-2 evolution and to predict future mutations of the virus, particularly those which lead to new variants. 

Prof. Aeyal Gross (Law) and team examined legal and public health implications of Israel’s “Green Pass” proof-of-vaccination rules under the country’s pandemic response. More here.  

Through big data methods, Prof. Tal Pupko’s (Life Sciences, Shmunis School) found that the swift implementation of lockdowns, rather than their strictness, was more effective in reducing COVID-19 mortality rates. More here.  

New Findings on the Horizon

Currently, the TAU researchers from the Center have approximately 30 ongoing coronavirus projects, including:  

Prof. Dan Peer (Life Sciences), TAU Vice President for Research & Development, is exploring best practices to advance the bourgeoning technology behind non-viral mRNA vaccines. 

Prof. Adi Stern’s (Life Sciences, Shmunis) lab has been studying the evolution of SARS-CoV-2, including the origin and behavior of the Omicron variant. More here.  

Prof. Ron Shamir (Exact Sciences) has teamed up with local hospitals to explore early predictors of deterioration in COVID-19 patients using machine-learning and “big data” methods. 

Prof. Yael Benyamini (Social Sciences) is leading a broad study on pregnancy and childbirth that surveyed the concerns of pregnant women about childbearing amid COVID-19. 

Prof. Miri Yemini (Humanities) & Dr. Efrat Blumenfeld (Arts) are leading an urban-sociological examination of remote teaching and learning during times of social distancing. 

Upcoming Events

In March, the Center plans to hold its first international conference to highlight recent COVID-19 research. The event will also recognize trailblazing research fellows and grant recipients. For registration and updates, visit: https://en-pandemics.tau.ac.il/save-the-date-first-tccp-convention .

Featured News: More than 100 research groups from all scientific disciplines across TAU campus are on the frontlines of the pandemic battle. (Photo: Moshe Bedarshi)

Related posts

Hyperbaric Treatment More Effective than Medicines for Fibromyalgia Caused by Head Injury

24 March 2023

Promoting Women in Medicine

9 March 2023

#TAU_WOMEN_POWER

7 March 2023

Researchers Discover Mechanism that Facilitates Formation of Brain Metastases

27 February 2023

Light Pollution is Killing Desert Rodents

10 February 2023

Three Tel Aviv University Researchers Awarded the ERC Proof of Concept (PoC) grants

9 February 2023

Researchers Identify A New Genetic Risk Factor for Age-related Eye Disease

8 February 2023

People With Autism Experience Pain at a Higher Intensity

31 January 2023

Researchers Uncover New Factors Linked to Williams Syndrome

24 January 2023

Lessons in Tolerance and DNA Extraction in Tel Aviv University’s Medical Labs

18 January 2023

Medical Clowns – No Laughing Matter

18 January 2023

Tel Aviv University’s First MedTech Hackathon Sets a High Bar

15 January 2023

Researchers use Smartwatches to Measure Safety of COVID Vaccine

28 December 2022

Tel Aviv University Establishes Multidisciplinary Center for Research of Autoimmune Diseases

18 December 2022

Breakthrough in the Field of Controlled Drug Delivery

16 December 2022

Common Medications May Reduce Risk of Metastases after Colon and Rectal Cancer

9 December 2022

Victoria

Tok Corporate Centre, Level 1,
459 Toorak Road, Toorak VIC 3142
Phone: +61 3 9296 2065
Email: office@aftau.asn.au

New South Wales

Level 22, Westfield Tower 2, 101 Grafton Street, Bondi Junction NSW 2022
Phone: +61 418 465 556
Email: davidsolomon@aftau.org.au

Western Australia

P O Box 36, Claremont,
WA  6010
Phone: :+61 411 223 550
Email: clivedonner@thelinqgroup.com